Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dec 1, 2020
The Source Winter 2020
Magazine of the plasma protein therapeutics industry - Winter 2020
All
The Source Magazine
https://drive.google.com/file/d/1UOI5Vo3ICyAgqZ_pLX7NEzgNhugvJEWb/view?usp=sharing
Dec 1, 2020
The Source Winter 2020
Magazine of the plasma protein therapeutics industry - Winter 2020
All
The Source Magazine
https://drive.google.com/file/d/1UOI5Vo3ICyAgqZ_pLX7NEzgNhugvJEWb/view?usp=sharing
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
Nov 19, 2020
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
November 18, 2020 (Brussels, Belgium) The Plasma Protein Therapeutics Association (PPTA) welcomes the European Commission’s publication of the Inception Impact Assessment (IIA) as a necessary step in the ongoing evaluation of the EU legislation on blood, tissues, and cells (BTC).
All
Press releases
Nov 19, 2020
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
November 18, 2020 (Brussels, Belgium) The Plasma Protein Therapeutics Association (PPTA) welcomes the European Commission’s publication of the Inception Impact Assessment (IIA) as a necessary step in the ongoing evaluation of the EU legislation on blood, tissues, and cells (BTC).
All
Press releases
Nov 4, 2020
PPTA Statement on the Urgent Need for Plasma Donation
COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies for all patients.
All
PPTA statements
Nov 4, 2020
PPTA Statement on the Urgent Need for Plasma Donation
COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies for all patients.
All
PPTA statements
No results found